Global Pharmacogenomics Technology Market Size & Outlook
Global pharmacogenomics technology market, 2018-2030 (US$M)
Related Markets
Global pharmacogenomics technology market highlights
- The global pharmacogenomics technology market generated a revenue of USD 7,633.2 million in 2024 and is expected to reach USD 12,380.1 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.1% by 2030.
- In terms of segment, oncology accounted for a revenue of USD 3,357.6 million in 2024.
- Cardiovascular Disease is the most lucrative therapeutics area segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 7,633.2 million |
| Market revenue in 2030 | USD 12,380.1 million |
| Growth rate | 8.1% (CAGR from 2025 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Cardiovascular Disease |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurological Disorders, Cardiovascular Disease, Immunological Disorders, Infectious Diseases, Oncology |
Other key industry trends
- In terms of revenue, the North America accounted for 36.8% of the global pharmacogenomics technology market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 14.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmacogenomics Technology Market Scope
Pharmacogenomics Technology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Leica Biosystems | View profile | 1001-5000 | Nußloch, Baden-Wurttemberg, Germany, Europe | http://www.leicabiosystems.com/ |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.foundationmedicine.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global pharmacogenomics technology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmacogenomics technology market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 43.99% in 2024. Horizon Databook has segmented the Global pharmacogenomics technology market based on neurological disorders, cardiovascular disease, immunological disorders, infectious diseases, oncology covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Pharmacogenomics Technology Therapeutics Area Outlook (Revenue, USD Million, 2018-2030)
- Others
- Cardiovascular Disease
- Neurological Disorders
- Infectious Diseases
- Immunological Disorders
- Oncology
- Colorectal Cancer
- Breast Cancer
- Cervical Cancer
- Others
- Lung Cancer
- Global Pharmacogenomics Technology Technology Outlook (Revenue, USD Million, 2018-2030)
- Immunohistochemistry
- PCR
- In-situ Hybridization
- Others
- Sequencing
Reasons to subscribe to Global pharmacogenomics technology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pharmacogenomics technology market databook
-
Our clientele includes a mix of pharmacogenomics technology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmacogenomics technology market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmacogenomics technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global pharmacogenomics technology market size, by regions, 2018-2030 (US$M)
Top 10 countries: Pharmacogenomics technology market size, 2024 (US$M)
Global pharmacogenomics technology market share, by technology, 2024 & 2030 (%, US$M)
Pharmacogenomics technology market: Opportunity assessment by country
Global pharmacogenomics technology market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
